FIELD: chemistry.
SUBSTANCE: invention relates to pharmaceutical chemistry and specifically 2-methoxy-4-[(3aR,7aS8)-3,3,6-trimethyl-1,3,3a,4,5,7a-hexahydro-2-benzofuran-1-yl]phenol of formula 1, , having anti-Parkinson activity and can be used in medicine.
EFFECT: agent has low toxicity and can be obtained from common natural compounds 2- and 3-carenes.
5 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
MEDICATION FOR TREATING PARKINSON'S DISEASE | 2009 |
|
RU2418577C1 |
2-((1-(4R-BENZYL)-1H-1,2,3-TRIAZOL-4-YL)METHOXY)-3-METHYL-6-(PROP-1-en-2-YL)CYCLOHEX-3-en-1-ol AS ANTIPARKINSONIAN AGENT | 2023 |
|
RU2812081C1 |
2-((1H-1,2,4-TRIAZO-3-YL)THIO)-3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-3-EN-1-OL AS AN ANTIPARKINSONIAN AGENT | 2022 |
|
RU2796729C1 |
3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-3-EN-1,2-DIOL- EPOXIDES - NEW ANTIPARKINSONIAN DRUGS AND ANTI-CONVULSANTS | 2014 |
|
RU2571299C1 |
AGENT FOR TREATMENT AND PREVENTION OF PARKINSON'S DISEASE | 2006 |
|
RU2324492C1 |
INJECTABLE DOSAGE FORM FOR TREATMENT OF PARKINSON'S DISEASE, METHOD FOR PREPARING AND USING IT | 2011 |
|
RU2520758C2 |
NOVEL USING SUBSTITUTED AMINOMETHYLCHROMANS IN TREATMENT OF MOTION DISORDER OR UNDESIRABLE EFFECT CAUSED BY AGENTS THAT ARE ADMINISTRATED IN TREATMENT OF EXTRAPYRAMID MOTION DISORDER | 2002 |
|
RU2320336C2 |
ADAMANTYL DERIVATIVES OF BENZIMIDAZOLE, HAVING ANTIPARKINSONIAN ACTIVITY | 2023 |
|
RU2820315C1 |
METHOD OF CORRECTING TREMOR IN EXPERIMENT | 2018 |
|
RU2678977C1 |
BIOLOGICALLY ACTIVE HETEROGLYCOSIDE FOR CORRECTION OF PATHOLOGICAL STATES OF CENTRAL NERVOUS SYSTEM | 2006 |
|
RU2335289C2 |
Authors
Dates
2011-12-20—Published
2010-06-10—Filed